Medical Bulletin 12/December/2023 Roshni Dhar12 Dec 2023 3:00 PM ISTHere are the top medical news of the day:Telehealth mindfulness recovery effective than usual care in individuals with opioid use disorder and painThe...
Bristol Myers Squibb, SystImmune collaborate for development, commercialization of BL-B01D1 Ruchika Sharma12 Dec 2023 12:30 PM ISTPrinceton: SystImmune, a clinical-stage biopharmaceutical company, and Bristol Myers Squibb have announced an exclusive license and collaboration...
Even little physical activity could be valuable in late-stage lung cancer Roshni Dhar12 Dec 2023 9:30 AM ISTNew research has found less than five minutes of daily physical activity could be linked with prolonged life in people living with inoperable forms of...
Type of Allergy medicine may have role in treatment of lung cancer Dr. Kamal Kant Kohli11 Dec 2023 9:45 AM ISTUSA: A recent study published in Nature has identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Durvalumab safely improves survival in lung cancer patients with limited physical function Dr. Kamal Kant Kohli1 Dec 2023 9:00 AM ISTUSA: A recent study published in eClinicalMedicine has shown single-agent durvalumab to be safe and well tolerated in the first-line treatment of...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
USFDA nod to Bristol Myers Squibb Augtyro for lung cancer Ruchika Sharma16 Nov 2023 5:30 PM ISTAugtyro is designed to minimize interactions that can lead to certain forms of treatment resistance in ROS1-positive metastatic NSCLC patients.
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
AstraZeneca-Daiichi Sankyo Enhertu approved in EU for lung cancer Ruchika Sharma24 Oct 2023 1:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the...
Medical Bulletin 19/October/2023 Roshni Dhar19 Oct 2023 3:15 PM ISTLung cancer treatment research enters a new eraAdvances in lung cancer treatment highlight importance of tumour testing at diagnosisResearch presented...
